Appointed: October 2020
Vincent Touraille was appointed Chief Strategy and M&A Officer at EUROAPI in 2020. His tasks include corporate strategy but also the team management for platforms, products strategy and partnerships.
Vincent has worked in the pharmaceutical industry for more than 20 years, developing his expertise in management and strategy. He started at Shell in 1989 and hold different growing positions. From 2009 to 2019, he served as Chief Executive Officer of PCAS, a French stock market listed CDMO acquired by Novacap in 2018.
In 2019, as Deputy Chief Executive Officer at M2i Lifesciences, he reorganized the company and led its evolution into a medium-sized international group.
Since October 2020, Vincent has been Head of Strategy at Sanofi Active Ingredient Solutions, where he has prepared the launch of EUROAPI as a standalone company.
He graduated from ENSCP (National Graduate School of Chemistry, Paris) in 1986 and ESSEC in 1989.
Vincent is Board member of France Chimie, the French chemical Society and the President of SICOS Biochimie, the representative body for manufacturers of fine chemicals located in France. He is also Board Member of European Fine Chemical Group, its European equivalent.
Vincent is passionate about spending time with family, reading novels and history. He regularly practices tennis and running.